Global Diabetic Nephropathy Market To Reach $3.3 Billion By 2031, Growing At A CAGR Of 6%
The global diabetic nephropathy market was valued at $1.9 billion in 2021, and is projected to reach $3.3 billion by 2031, growing at a CAGR of 6%.
Healio2d
‘We applaud CMS’: Two more rheumatology drugs bound for Medicare price negotiation
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
pharmaphorum3d
Pharma holds it breath for ’25 as the sun shines on JP Morgan conference
The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...
Incretin-Based Drugs Market Size Projected To Reach USD 73.9 Billion By 2032 At A 7.9% CAGR, Says AMR
Rising prevalence of diabetes, recent product approvals & product launches in the market are the major factors driving the market for incretin-based drugs.